GO
Loading...

Actavis Inc

More

  • Oct 1- Watson Pharmaceuticals Inc:. *Confirms favorable district court ruling in androgelï¿ ½ 1% antitrust litigation. *Says court found that the plaintiffs' claims were unsustainable.

  • EU mergers and takeovers (Oct 1) Monday, 1 Oct 2012 | 8:58 AM ET

    BRUSSELS, Oct 1- The following are mergers under review by the European Commission and a brief guide to the EU merger process:. --Private equity firms Carlyle and BC Partners to acquire U.S. industrial pumps maker Hamilton Sundstrand Industrial which is owned by United Technologies Corp.

  • Fast Pros Reveal Favorites from Cooperman Top Picks Wednesday, 18 Jul 2012 | 12:52 PM ET

    Not everyone has the kind of capital Leon Cooperman has to buy stocks. From his 10 top picks, the Fast traders reveal their single favorites.

  • Stocks to Watch: CVX, MAR, SVU & More Wednesday, 11 Jul 2012 | 4:56 PM ET

    Check out which companies are making headlines after the bell Wednesday:

  • Stocks to Watch: SNDK, NFLX, BA & More Monday, 25 Jun 2012 | 7:57 AM ET

    Take a look at some of Monday’s morning movers:

  • Analysts Get Hooked On Watson After Actavis Deal Thursday, 26 Apr 2012 | 1:04 PM ET
    Watson Pharmaceuticals

    Although Watson Pharmaceuticals’ acquisition of Swiss generic drug maker Actavis was expected for over a month, a strong reaction to Wednesday’s deal shows that analysts are hooked on the drugmaker.

  • Stocks to Watch: XOM, PEP, UPS & More Thursday, 26 Apr 2012 | 8:24 AM ET

    Take a look at some of Thursday's morning movers.

  • Stocks to Watch: AKAM, CROX & More Wednesday, 25 Apr 2012 | 4:50 PM ET

    Check out which companies are making headlines after-the-bell Wednesday:

  • eBay Has Best Day Since 2008, Volume Spikes Thursday, 19 Apr 2012 | 2:32 PM ET

    Earlier in the trading session, eBay shares were up as much as 16.6 percent, their best intraday gain since Oct. 2008.

  • Watson Pharma Volume Spikes Thursday, 22 Mar 2012 | 3:44 PM ET

    Stocks in the S&P 1,500 displaying unusual volume in Thursday's trading session.

  • Stocks End Mixed; Nasdaq Hits 11-Year High Wednesday, 21 Mar 2012 | 4:23 PM ET

    Stocks ended narrowly mixed in a lackluster session Wednesday following a weaker-than-expected existing home sales report and as investors were reluctant to jump in following the recent market rally.

  • Top Investor Scott Black’s Favorite Stocks Thursday, 8 Mar 2012 | 6:48 PM ET
    Fast Money Portfolio

    Some of the steadiest growth stocks lie in pharmaceuticals and agricultural plays, one noted investor said Thursday.

  • Watson CEO on Generic Drug Market     Thursday, 23 Feb 2012 | 4:35 PM ET

    Generic medicines accounted for over 75% of prescriptions dispensed by retail drug stores in 2010. And today that number keeps growing. Paul Bisaro, Watson Pharmaceuticals CEO, provides industry perspective.

  • Your First Move For Tuesday February 14th Monday, 13 Feb 2012 | 6:47 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • What's Shaking: Monday's Early Movers Monday, 13 Feb 2012 | 8:19 AM ET

    Take a look at some of Monday morning's early movers:

  • Stocks Ends Mixed, S&P Snaps 5-Day Rally Tuesday, 24 Jan 2012 | 4:48 PM ET

    Stocks closed narrowly mixed in lackluster trading Tuesday, with the S&P breaking a 5-day winning streak, as Greece's failed debt restructuring negotiations and a handful of tepid earnings reports weighed on the market.

  • Futures Decline as Latest Greek Deal Rejected Tuesday, 24 Jan 2012 | 9:13 AM ET

    U.S. stock index futures pointed to a lower open Tuesday as concerns about the European debt crisis continued to weigh and as investors digested a handful of mixed corporate earnings reports.

  • Life After Lipitor     Wednesday, 30 Nov 2011 | 4:45 PM ET

    Discussing whether Pfizer doing enough to replace the lost revenue from Lipitor, with Tim Chiang, CRT Capital Group, and Catherine Arnold, Credit Suisse. They also discuss what a restructured Pfizer look like in 2012.

  • Nov. 30: Unusual Volume Leaders Wednesday, 30 Nov 2011 | 3:36 PM ET

    What follows is a look at stocks in the S&P 1,500 displaying unusual volume in Wednesday's trading session.

  • For the last year, Pfizer has been laying the groundwork to combat the looming competition against Lipitor, forging deals with insurers, pharmacy benefit managers and patients to meet or beat the price of its generic replacements, the New York Times reports.